Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Step 6: Avoid Rapid Lifestyle Changes Trying to change everything at once can feel overwhelming
The result has been shortages of the drug for diabetics who rely on it to lower their blood sugar, while doctors are also concerned it could be abused by those with eating disorders or others hoping for short-term weight loss
The drug is being developed by Eli Lilly and Company and remains under active investigation
Mean body weight at baseline for the 902 patients was 106.8 kg and mean BMI was 38.3 kg/m
doi:10.1016/S2352-3018(19)30338-8 31
BI 456906 (Amylin + GLP-1 dual agonist) BI 456906 is an investigational anti-obesity medication that acts as a dual agonist
US$ 29.60
US$ 26.63
US$ 25.24
US$ 23.49
US$ 20.69
US$ 26.18
